- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.90 Å
- Oligo State
- hetero-5-5-5-5-mer
- Ligands
- 5 x DOA: 12-AMINO-DODECANOIC ACID(Non-covalent)
- 5 x MYR: MYRISTIC ACID(Non-covalent)
MYR.2: 11 residues within 4Å:- Chain D: G.1, A.2, I.29, Y.31
- Chain H: T.27, N.28, I.29, Y.31
- Chain O: L.2
- Ligands: MYR.4, MYR.10
5 PLIP interactions:2 interactions with chain D, 2 interactions with chain H, 1 interactions with chain O- Hydrophobic interactions: D:I.29, H:N.28, H:I.29, O:L.2
- Hydrogen bonds: D:A.2
MYR.4: 11 residues within 4Å:- Chain H: G.1, A.2, I.29, Y.31
- Chain L: T.27, N.28, I.29, Y.31
- Chain S: L.2
- Ligands: MYR.2, MYR.6
5 PLIP interactions:2 interactions with chain L, 1 interactions with chain S, 2 interactions with chain H- Hydrophobic interactions: L:N.28, L:I.29, S:L.2, H:I.29
- Hydrogen bonds: H:A.2
MYR.6: 11 residues within 4Å:- Chain C: L.2
- Chain L: G.1, A.2, I.29, Y.31
- Chain P: T.27, N.28, I.29, Y.31
- Ligands: MYR.4, MYR.8
5 PLIP interactions:2 interactions with chain L, 2 interactions with chain P, 1 interactions with chain C- Hydrophobic interactions: L:I.29, P:N.28, P:I.29, C:L.2
- Hydrogen bonds: L:A.2
MYR.8: 11 residues within 4Å:- Chain G: L.2
- Chain P: G.1, A.2, I.29, Y.31
- Chain T: T.27, N.28, I.29, Y.31
- Ligands: MYR.6, MYR.10
5 PLIP interactions:2 interactions with chain P, 1 interactions with chain G, 2 interactions with chain T- Hydrophobic interactions: P:I.29, G:L.2, T:N.28, T:I.29
- Hydrogen bonds: P:A.2
MYR.10: 11 residues within 4Å:- Chain D: T.27, N.28, I.29, Y.31
- Chain K: L.2
- Chain T: G.1, A.2, I.29, Y.31
- Ligands: MYR.2, MYR.8
5 PLIP interactions:1 interactions with chain K, 2 interactions with chain D, 2 interactions with chain T- Hydrophobic interactions: K:L.2, D:N.28, D:I.29, T:I.29
- Hydrogen bonds: T:A.2
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Stuart, A. et al., Determination of the Structure of a Decay Accelerating Factor-Binding Clinical Isolate of Echovirus 11 Allows Mapping of Mutants with Altered Receptor Requirements for Infection. J.Virol. (2002)
- Release Date
- 2002-07-11
- Peptides
- ECHOVIRUS 11 COAT PROTEIN VP1: AEIMQ
ECHOVIRUS 11 COAT PROTEIN VP2: BFJNR
ECHOVIRUS 11 COAT PROTEIN VP3: CGKOS
ECHOVIRUS 11 COAT PROTEIN VP4: DHLPT - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
AI
AM
AQ
AB
BF
BJ
BN
BR
BC
CG
CK
CO
CS
CD
DH
DL
DP
DT
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.90 Å
- Oligo State
- hetero-5-5-5-5-mer
- Ligands
- 5 x DOA: 12-AMINO-DODECANOIC ACID(Non-covalent)
- 5 x MYR: MYRISTIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Stuart, A. et al., Determination of the Structure of a Decay Accelerating Factor-Binding Clinical Isolate of Echovirus 11 Allows Mapping of Mutants with Altered Receptor Requirements for Infection. J.Virol. (2002)
- Release Date
- 2002-07-11
- Peptides
- ECHOVIRUS 11 COAT PROTEIN VP1: AEIMQ
ECHOVIRUS 11 COAT PROTEIN VP2: BFJNR
ECHOVIRUS 11 COAT PROTEIN VP3: CGKOS
ECHOVIRUS 11 COAT PROTEIN VP4: DHLPT - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
AI
AM
AQ
AB
BF
BJ
BN
BR
BC
CG
CK
CO
CS
CD
DH
DL
DP
DT
D